USPTO serial 79226449
LUX
Reviewed by CopyMark Law Group
Reg. 5548009Status 709
- Filing date
- Status date
- Registration date
- Aug 28, 2018
- Examiner
- EINSTEIN, MATTHEW T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LUX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
GABRIELLE S. ROTH
GABRIELLE S. ROTH SUGHRUE MION, PLLC2100 PENNSYLVANIA AVENUE, N.W.WASHINGTON, DC 20037UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical and pharmaceutical preparations for medical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; chemical and pharmaceutical drug delivery preparations in the form of coatings for medical devices and balloons that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; pharmaceutical preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; drugs for medical purposes, namely, drugs for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; excipients, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in drug eluting balloons | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments, namely, catheters, catheters for percutaneous coronary intervention (PCI), catheters for percutaneous transluminal coronary angioplasty (PTCA catheters), catheters for percutaneous transluminal angioplasty (PTA catheters), catheters for balloon dilatation; medical apparatus, namely, balloons for vessel dilatation, balloons for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation, coronary and peripheral balloon catheters, drug eluting balloons, drug releasing balloons, drug coated balloons, stents and drug eluting stents | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 12, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 12, 2026 | INPC | INVALIDATION PROCESSED | — |
| Nov 14, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 14, 2025 | C71T | CANCELLED SECTION 71 | — |
| Aug 28, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 18, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 28, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 8, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 8, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 28, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 28, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 24, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 12, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 12, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 8, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 23, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 23, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 7, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 7, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 7, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 2, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 24, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 7, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 7, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 1, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 13, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 8, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |